Registro:

Referencias:

• Batlle, A., Humanas, P., Signos y Tratamientos. In Porfirias y Porfirinas. Aspectos clínicos, bioquímicos y biología molecular (1997) Acta Bioquim. Clin. Latinoam., 3 (2), pp. 37-69
• Schüler, A., Salamanca, R., (2000) Metabolismo de las Porfirinas y Porfirias, , Complutense, Madrid
• Cerbino, G., Gerez, E., Varela, L., Melito, V., Parera, V., Batlle, A., Rossetti, M., (2015), 2015, pp. 1-7. , Acute intermittent porphyria in Argentina. An update, J. Biomed. Biotech 4-; Hrdinka, M., Puy, H., Martasek, P., May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population (2006) Physiol. Res., 55, pp. S119-136
• Pischik, E., Kauppinen, R., Neurological manifestations of acute intermittent porphyria (2009) Cell. Mol. Biol. (Noisy-le-Grand), 55 (1), pp. 72-83
• Besur, S., Hou, W., Schmeltzer, P., Bonkovsky, H., Clinically important features of porphyrin and heme metabolism and the porphyrias (2014) Metabolites, 4 (4), pp. 977-1006
• Park, E., Yi Seul, K., Kyung-Jee, L., Hye Kyoung, L., Soo Kyung, L., Hyun, C., Mae-Hwa, K., Severe neurologic manifestations in acute intermittent porphyria developed after spine surgery under general anesthesia -a case report (2014) Korean J. Anesthesiol., 67 (3), pp. 217-220
• Thunell, S., Pomp, E., Brun, A., Guide to drug porphyrogenicity prediction and drug prescription in the acute porphyrias (2007) Br. J. Clin. Pharmacol., 64 (5), pp. 668-679
• Demasi, M., Penalti, C., DeLucia, R., Bechara, E., The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias (1996) Free Rad. Biol. Med., 20 (3), pp. 291-299
• Emanuelli, T., Pagel, F., Porciuncula, L., Souza, D., Effects of 5-aminolevulinic acid on the glutamatergic neurotransmission (2003) Neurochem. Int., 42, pp. 115-121
• Adhikari, A., Penatti, C., Resende, R., Ulrico, H., Britto, L., Bechara, E., 5-aminolevulinate and 4, 5-dioxovalerate ions decrease GABA(A) receptor density in neuronal cells, synaptosomes and rat brain (2006) Brain Res., 1093 (1), pp. 95-104
• Felitsyn, N., McLeod, C., Shroads, A., Stacpoole, P., Notterpek, L., The heme precursor delta-aminolevulinate blocks peripheral myelin formation (2008) J. Neurochem., 106 (5), pp. 2068-2079
• Takeda, A., Itoyama, Y., Kimpara, T., Kutty, R., Abraham, N., Dwyer, B., Petersen, R., Smith, M., Role of heme catabolism in neurodegenerative diseases (2002) Heme Oxygenase in Biology and Medicine, pp. 135-143. , N.G. Abraham Kluwer Acad. Publ. N.Y
• Maines, M., Gibbs, P., 30 some years of heme oxygenase: from a “molecular wrecking ball” to a “mesmerizing” trigger of cellular events (2005) Biochem. Biophys. Res. Commun., 338 (1), pp. 568-577
• Abraham, N., Kappas, A., Pharmacological and clinical aspects of heme oxygenase (2008) Pharmacol. Rev., 60 (1), pp. 79-127
• Buzaleh, A., Enriquez de Salamanca, R., Batlle, A., Administration of the anesthetic isoflurane to mice: a model for acute intermittent porphyria? (1992) J. Pharmacol. Toxicol. Methods, 28 (4), pp. 191-197
• Sampayo, R., Lavandera, J., Batlle, A., Buzaleh, A., Sevoflurane: its action on heme metabolism and phase I drug metabolizing system (2009) Cell. Mol. Biol. (Noisy-le-Grand), 55 (2), pp. 140-146
• Buzaleh, A., Morán-Jiménez, M., García-Bravo, M., Sampedro, A., Batlle, A., Enríquez de Salamanca, R., Fontanellas, A., Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria (2009) Cell. Mol. Biol., 55 (1), pp. 38-44
• Buzaleh, A., García Bravo, M., Navarro, S., Morán Jimenez, M., Méndez, M., Batlle, A., Fontanellas, A., Enríquez de Salamanca, R., Volatile anaesthetics induce biochemical alterations in the heme pathway in a B-lymphocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cells (2004) Int. J. Biochem. Cell Biol., 36 (2), pp. 216-222
• Rodríguez, J., Buzaleh, A., Fossati, M., Azcurra, J., Batlle, A., The effects of some porphyrinogenic drugs on the brain cholinergic system (2002) Cell. Mol. Biol., 48 (1), pp. 103-110
• Rodriguez, J., Martinez, M., Gerez, E., Batlle, A., Buzaleh, A., Heme oxygenase, aminolevulinate acid synthetase and the antioxidant system in the brain of mice treated with porphyrinogenic drugs (2005) Cell. Mol. Biol. (Noisy-le-Grand), 51 (5), pp. 487-494
• Lavandera, J., Batlle, A., Buzaleh, A., Metabolization of porphyrinogenic agents in brain: involvement of the phase I drug metabolizing system. A comparative study in liver and kidney (2007) Cell. Mol. Neurobiol., 27 (6), pp. 717-729
• Lavandera, J., Fossatti, M., Azcurra, J., Batlle, A., Buzaleh, A., Glutamatergic system: another target for the action of porphyrinogenic agents (2009) Cell. Mol. Biol., 55 (1), pp. 23-28
• Lavandera, J., Batlle, A., Buzaleh, A., Mice brain nitric oxide synthase response induced by anaesthetics and other porphyrinogenic drugs (2011) Drug Metab. Lett., 5 (1), pp. 25-29
• Lavandera, J., Ruspini, S., Batlle, A., Buzaleh, A., https://doi.org/10.1139/bcb-2014-0088, Cytochrome P450 expression in mouse brain: specific isoenzymes involved in phase I metabolizing system of porphyrinogenic agents in both microsomes and mitochondria, Biochem. Cell Biol. 92(1) (2014) 1–6; Lindberg, R., Porcher, C., Grandchamp, B., Ledermann, B., Bürki, K., Brandner, S., Aguzzi, A., Meyer, U., Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria (1996) Nat. Genet., 12 (2), pp. 195-199
• Lindberg, R.L.P., Martini, R., Baumgartner, M., Erne, B., Borg, J., Zielasek, J., Ricker, K., Meyer, U.A., Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria (1999) J. Clin. Invest., 103, pp. 1127-1134
• Jover, R., Hoffmann, F., Scheffler-Koch, V., Lindberg, R.L.P., Limited heme synthesis in porphobilinogen deaminase-deficient mice impairs transcriptional activation of specific cytochrome P450 genes by phenobarbital (2000) Eur. J. Biochem., 267, pp. 7128-7137
• Johansson, A., Möller, C., Fogh, J., Harper, P., Biochemical chacterization of porphobilinogen deaminase-deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement (2003) Mol. Med., 9, pp. 193-199
• Balwani, M., Desnick, R., The porphyrias: advances in diagnosis and treatment (2012) Blood, 120 (23), pp. 4496-4504
• Miksys, S., Tyndale, R.F., Cytochrome P450-mediated drug metabolism in the brain (2013) J. Psychiatry Neurosci., 38 (3), pp. 152-163
• Ortiz de Montellano, P., Mico, B., Yost, G., Suicidal inactivation of cytochrome P450. Formation of heme-substrate covalent adduct (1987) Biochem. Biophys. Res. Commun., 83 (1), pp. 132-137
• Handschin, C., Lin, J., Rhee, J., Peyer, A.K., Chin, S., Wu, P.H., Meyer, U.A., Spiegelman, B.M., Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha (2005) Cell, 122 (4), pp. 505-515
• Paredes, S.R., Kozicki, P.A., Fukuda, H., Rossetti, M.V., Batlle, A., S-adenosyl-L-methionine: its effect on aminolevulinate dehydratase and glutathione in acute ethanol intoxication (1987) Alcohol, 4 (2), pp. 81-85
• Marver, H., Tschudy, D., Perlroth, M., Collins, A., Delta-aminolevulinic acid synthetase. I. Studies in liver homogenates (1996) J. Biol. Chem., 241 (12), pp. 2803-2809
• Batlle, A., Wider de Xifra, E., Stella, A., A simple method for measuring erythrocyte porphobilinogenase and its use in the diagnosis of acute intermittent porphyria (1978) Int. J. Biochem., 9 (12), pp. 871-875
• Tenhunen, R., Marver, H., Schmid, R., The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin (1970) J. Lab. Clin. Med., 75 (3), pp. 410-421
• Reinke, L.A., Moyer, M.J., p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol (1985) Drug Metab. Dispos., 13 (5), pp. 548-552
• Oliveri, L.M., Davio, C., Del, A.M., Batlle, C., Gerez, E.N., ALAS1 gene expression is down-regulated by Akt-mediated phosphorylation and nuclear exclusion of FOXO1 by vanadate in diabetic mice (2012) Biochem. J., 442, pp. 303-310
• Lowry, O., Rosebrough, N., Farr, A., Randall, R., Protein measurement with the folin-phenol reagent (1951) J. Biol. Chem., 193 (1), pp. 265-275
• Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal. Biochem., 72, pp. 248-254
• Furuyama, K., Kaneko, K., Vargas, P., Heme as a magnificent molecule with multiple missions: heme determines its own fate and governs cellular homeostasis (2007) Tohoku J. Exp. Med., 213 (1), pp. 1-16
• Chiabrando, D., Vinchi, F., Fiorito, V., Mercurio, S., Tolosano, E., Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes (2014) Front. Pharmacol.
• Buzaleh, A., Batlle, A., Strain and sex differences in the effect of Enflurane and isoflurane on heme metabolism in mice (1996) Gen. Pharmacol., 27 (6), pp. 1009-1012
• Knockaert, L., Fromenty, B., Robin, M.A., Mechanisms of mitochondrial targeting of cytochrome P450 2E1: physiopathological role in liver injury and obesity (2011) FEBS J., 278 (22), pp. 4252-4260
• Buzaleh, A.M., Vázquez, E., Enríquez de Salamanca, R., Batlle, A., An overview on anesthesia and porphyrias (review) (1997) Endocrinol. Metab., 4, pp. 267-279
• Martínez, M.D.C., Buzaleh, A.M., Batlle, A., Efecto de la administración de los anestésicos Enflurano e Isoflurano a ratones con niveles inducidos y deprimidos de Citocromo P450. Estudios sobre el sistema enzimático metabolizante de drogas (2000) Acta Bioquim. Clin. Latinoam., 39, pp. 37-42
• Unzu, C., Sampedro, A., Sardh, E., Mauleon, I., Enrıquez de Salamanca, R., Prieto, J., Salido, E., Fontanellas, A., Renal failure affects the enzymatic activities of the three first steps in hepatic heme biosynthesis in the acute intermittent porphyria mouse (2000) PLoS One, 7 (3). , e32978 1–e32978 9
• Tomaro, M., Batlle, A., Bilirubin: its role in cytoprotection against oxidative stress (2002) Int. J. Biochem. Cell Biol., 34 (3), pp. 216-220
• Gerjevic, L., Lu, S., Chaky, J., Harrison-Findik, D., Regulation of heme oxygenase expression by alcohol, hypoxia and oxidative stress (2011) World J. Biol. Chem., 2 (12), pp. 252-260
• Burchell, B., Dixon, J., Tang, Zhang, J., Isoflurane provides neuroprotection in neonatal hypoxic ischemic brain injury (2013) J. Investig. Med., 61 (7), pp. 1078-1083

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------